Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) of Patients Intolerant to, or Dependant on, Topical Corticosteroids

NCT00121316 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00121316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00121316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) of Patients Intolerant to, or Dependant on, Topical Corticosteroids
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2004
Completion date
July 31, 2005
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis